Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 22, 2018
Pharmacy Choice - News - Over-the-Counter Drugs - February 22, 2018

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 30     Next >>     Go To Page:

2/21/18 - JOHNSON & JOHNSON - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION
Organization and Business Segments Description of the Company and Business Segments Johnson& Johnson and its subsidiaries have approximately 134,000 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The Company conducts business in virtually all countries of the.
2/21/18 - Nutra Pharma Files Provisional Patent for Nerve Agent Counter Measures
via OTC PR WIRE Nutra Pharma Corporation, a biotechnology company marketing Nyloxin and Pet Pain-Away? in the over-the-counter pain management market, and which is also developing treatments for Multiple Sclerosis, Human Immunodeficiency Virus, Adrenomyeloneuropathy and Pain, announced today that they have filed a new provisional patent to
2/21/18 - Perrigo Confirms Patent Challenge For Generic Version Of Finacea Foam, 15%
DUBLIN- Perrigo Company plc today announced that it has filed a Paragraph IV Abbreviated New Drug Application with the U.S. Food and Drug Administration for a generic version of Finacea Foam. Following notification from Perrigo, Bayer AG filed a patent litigation suit asserting patents listed in the Orange Book for Finacea Foam in the United States
2/21/18 - Skinvisible, Inc. (SKVI) Aims to Increase Shareholder Value through Proposed Deal with Quoin
Drug delivery platform ideal for M&A-driven growth $80 billion global dermatology market $30 billion global over-the-counter skincare market Half of the 100 million surgeries performed in the U.S. require post-surgical pain medication, according to Transparency Market Research report. If history repeats itself, as we are often told, then Skinvisibl
2/20/18 - Caught in the Mill: Pain Doctors Say They're POWs in the War on Opioids
Daniel Maynard was the first red flag in Dallas. It was a neighborhood of South Dallas known for its pain, and Maynard treated it. He wrote more than 54,000 prescriptions in 2002 and wrote more scripts for Valium than any other doctor in Texas.
2/20/18 - Global Over-the-Counter (OTC) Drug Markets, 2023: CNS Agents, Dermatological Agents, Gastrointestinal System Agents, Respiratory System Agents & Others [Tehran Times (Iran)]
-The "Global Over-the-Counter Drug Markets" report has been added to ResearchAndMarkets.com `s offering. The global over-the-counter drug market is highly fragmented by region. By definition, the FDA has found them to be safe for use without medical supervision.
2/20/18 - Ortho Dermatologics Presents an Analysis of SILIQ Injection Phase 3 Data on Disease-Related Anxiety and Depression in Patients with Moderate-To-Severe Plaque Psoriasis
LAVAL, Quebec- Ortho Dermatologics, a division of Valeant Pharmaceuticals North America, LLC, today announced results from an analysis of the Phase 3 clinical trial AMAGINE-1, which evaluated mental health comorbidities associated with psoriasis, such as anxiety and depression. These findings were presented for the first time at the 76th Annual Mee
2/20/18 - Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet by Company's Subsidiary Macoven Pharmaceuticals
MORRISTOWN- Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced the launch of an authorized generic version of Treximet in the U.S. by the Company's subsidiary, Macoven Pharmaceuticals, LLC. 'The availability of both a branded and authorized generic version of Treximet demonstrates that Pernix continues to view T
2/20/18 - Perrigo Confirms Patent Challenge For Generic Version Of Finacea Foam, 15%
Perrigo Company plc today announced that it has filed a Paragraph IV Abbreviated New Drug Application with the U.S. Food and Drug Administration for a generic version of Finacea Foam. Following notification from Perrigo, Bayer AG filed a patent litigation suit asserting patents listed in the Orange Book for Finacea Foam in the United States
2/20/18 - Singapore Pharmaceutical Market To Reach $530 Million, With A CAGR Of 6.40% During The Forecast Period 2016-2024
Singapore Pharmaceutical Market is estimated to reach USD 530 million by 2024 at the considerable CAGR of 6.4% over the forecast period.More than 30 Medtech companies have invested for research& development and in setting up pharmaceutical manufacturing plants in Singapore. In 2012, as per Singapore Economic Development Board, pharmaceutical...
2/20/18 - Wize Pharma Receives IRB Approval of Phase IV Study Protocol for LO2A in Symptomatic Treatment of Dry Eye Syndrome in Patients With Sjgren's Syndrome
HOD HASHARON, Israel, Feb. 20, 2018/ PRNewswire/ Wize Pharma, Inc., a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, today announced it has received Institutional Review Board approval for the protocol of its planned Phase IV study. The study will take place in Israel and will evaluate the saf
2/19/18 - Global Over-the-Counter (OTC) Drug Markets 2017-2023: Johnson & Johnson Maintains a Top Market Position Despite Growing Consolidation and Competition
The "Global Over-the-Counter Drug Markets" report has been added to ResearchAndMarkets.com' s offering. The report includes discussions of conditions often treated with OTC medicines, health statistics related to the industry, global populations, aging populations, populations by region and issues affecting the market as a whole. Information is pre
2/19/18 - Global Over-the-Counter (OTC) Drug Markets 2017-2023: Johnson & Johnson Maintains a Top Market Position Despite Growing Consolidation and Competition - ResearchAndMarkets.com
The "Global Over-the-Counter Drug Markets" report has been added to ResearchAndMarkets.com' s offering. The report includes discussions of conditions often treated with OTC medicines, health statistics related to the industry, global populations, aging populations, populations by region and issues affecting the market as a whole. Information is pre
2/19/18 - Global Over-the-Counter (OTC) Drug Markets Report 2018: Perrigo Is the Leading Off-Brand OTC Drug Company
The "Global Over-the-Counter Drug Markets" report has been added to ResearchAndMarkets.com' s offering. The global over-the-counter drug market is highly fragmented by region. By definition, the FDA has found them to be safe for use without medical supervision.
2/19/18 - Global Over-the-Counter (OTC) Drug Markets, 2023: CNS Agents, Dermatological Agents, Gastrointestinal System Agents, Respiratory System Agents & Others
The "Global Over-the-Counter Drug Markets" report has been added to ResearchAndMarkets.com' s offering.. The global over-the-counter drug market is highly fragmented by region. By definition, the FDA has found them to be safe for use without medical supervision.
2/19/18 - Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group INC
Vancouver, BC- Isodiol International Inc., a global CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a Definitive Agreement to acquire 100% of Canadian National Pharma Group Inc., a pharmaceutical manufacturing company. Once approved by Health Canada, CN Pharma wi
2/19/18 - SeeThruEquity Issues Update on Innovus Pharmaceuticals with Target Price of $0.70
NEW YORK- SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has issued an update on Innovus Pharmaceuticals, Inc. with a target price of $0.70. Bassam Damaj, Innovus is based in San Diego, CA and has demonstrated robust growth in its product offerings
2/17/18 - Acerus Pharma's NATESTO to Be Listed for Public Reimbursement in Quebec, Building on Strong 28% Increase in Natesto's Canadian Prescriptions in Q4...
By a News Reporter-Staff News Editor at Marketing Weekly News Acerus Pharmaceuticals Corporation announced that it has received notice from Quebec's National Institute for Excellence in Health and Social Services of a positive recommendation to the Health Minister for the inclusion of NATESTO on the list of medications of the Regie de l'assura
2/16/18 - Capillus to Attend the American Academy of Dermatology's Annual Meeting in San Diego
Capillus, LLC will be exhibiting during the American Academy of Dermatology's 2018 AAD Annual Meeting, which is taking place at the San Diego Convention Center in San Diego, California from February 16th- 20th, 2018. Capillus will be located in Booth #3729 in the main aisle of the convention center's exhibition hall. Visitors to their booth will be
2/16/18 - DEC Announces 172 Pharmacies, Hospitals and Long-Term Care Facilities Participating in 2nd Round of State's Pilot Drug 'Take-Back' Program
The New York State Department of Environmental Conservation issued the following news release:. New York State Department of Environmental Conservation Commissioner Basil Seggos today announced the second group of participants in the State's $2 million Pilot Pharmaceutical Take-Back Program. "The hundreds of pharmacies and facilities participating
2/16/18 - Isodiol International Inc. Signs Definitive Agreement to Acquire 100% Of Canadian National Pharma Group Inc. [Sudan Tribune]
-Isodiol International Inc., a global CBD innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has entered into a Definitive Agreement to acquire 100% of Canadian National Pharma Group Inc., a pharmaceutical manufacturing company. Isodiol previously announced on Dec. 6th, 2017 the agreeme
2/16/18 - KNH Unveils Antibiotics Usage Guidelines
Kenyatta National Hospital has taken the lead to develop clinical guidelines to curb potential antibiotics drug resistance. The guidelines, recently developed with support from global biopharmaceutical firm, MSD have been designed to provide a standard practice platform for all health workers at KNH responsible for the dispensing and application of
2/16/18 - New TREMFYA (guselkumab) Data Demonstrates Long-Term Skin Clearance In Patients With Moderate To Severe Plaque Psoriasis
The Janssen Pharmaceutical Companies of Johnson& Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA who achieved at least 90 percent improvement in the Psoriasis Area and Severity Index at week 28, maintained a PASI 90 response with continuous treatment through we
2/16/18 - Ortho Dermatologics Presents An Analysis Of SILIQ? (Brodalumab) Injection Phase 3 Data On Disease-Related Anxiety And Depression In Patients With Moderate-To-Severe Plaque Psoriasis
Ortho Dermatologics, a division of Valeant Pharmaceuticals North America, LLC, today announced results from an analysis of the Phase 3 clinical trial AMAGINE-1, which evaluated mental health comorbidities associated with psoriasis, such as anxiety and depression. These findings were presented for the first time at the 76 th Annual Meeting of the
2/16/18 - Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet by Company's Subsidiary, Macoven Pharmaceuticals
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, today announced the launch of an authorized generic version of Treximet in the U.S. by the Company s subsidiary, Macoven Pharmaceuticals, LLC. Treximet is a prescription medicine that contains sumatriptan and naproxen sodium and is indicated for the treatment of acute m
Articles(s): 1 - 25 of 30     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415